News Release 

Examining oncology clinical trials launched before, during COVID-19 pandemic

JAMA Network Open

Research News

What The Study Did: 
Researchers evaluated the association between the pandemic and clinical research and development by studying the initiation of oncology clinical trials over time.

Authors: 
Elizabeth B. Lamont, M.D., M.S., M.MSc., of Acorn AI by Medidata, a Dassault Systèmes Company, in Boston, is the corresponding author.

To access the embargoed study:
Visit our For The Media website at this link
https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.36353)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:
The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article 
This link will be live at the embargo time
http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.36353?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=012721

About JAMA Network Open: 

JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.